001010512 001__ 1010512
001010512 005__ 20231027114413.0
001010512 0247_ $$2doi$$a10.1667/RADE-22-00206.1
001010512 0247_ $$2ISSN$$a0033-7587
001010512 0247_ $$2ISSN$$a1938-5404
001010512 0247_ $$2datacite_doi$$a10.34734/FZJ-2023-03095
001010512 0247_ $$2pmid$$a37057982
001010512 0247_ $$2WOS$$aWOS:001004143500007
001010512 037__ $$aFZJ-2023-03095
001010512 041__ $$aEnglish
001010512 082__ $$a530
001010512 1001_ $$0P:(DE-HGF)0$$aAbend, M.$$b0$$eCorresponding author
001010512 245__ $$aRENEB Inter-Laboratory Comparison 2021: The Gene Expression Assay
001010512 260__ $$aGreat Falls, Va.$$bRadiation Research Society$$c2023
001010512 3367_ $$2DRIVER$$aarticle
001010512 3367_ $$2DataCite$$aOutput Types/Journal article
001010512 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1692363277_8451
001010512 3367_ $$2BibTeX$$aARTICLE
001010512 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001010512 3367_ $$00$$2EndNote$$aJournal Article
001010512 520__ $$aEarly and high-throughput individual dose estimates are essential following large-scale radiation exposure events. In the context of the Running the European Network for Biodosimetry and Physical Dosimetry (RENEB) 2021 exercise, gene expression assays were conducted and their corresponding performance for dose-assessment is presented in this publication. Three blinded, coded whole blood samples from healthy donors were exposed to 0, 1.2 and 3.5 Gy X-ray doses (240 kVp, 1 Gy/min) using the X-ray source Yxlon. These exposures correspond to clinically relevant groups of unexposed, low dose (no severe acute health effects expected) and high dose exposed individuals (requiring early intensive medical health care). Samples were sent to eight teams for dose estimation and identification of clinically relevant groups. For quantitative reverse transcription polymerase chain reaction (qRT-PCR) and microarray analyses, samples were lysed, stored at 20°C and shipped on wet ice. RNA isolations and assays were run in each laboratory according to locally established protocols. The time-to-result for both rough early and more precise later reports has been documented where possible. Accuracy of dose estimates was calculated as the difference between estimated and reference doses for all doses (summed absolute difference, SAD) and by determining the number of correctly reported dose estimates that were defined as ±0.5 Gy for reference doses <2.5 Gy and ±1.0 Gy for reference doses >3 Gy, as recommended for triage dosimetry. We also examined the allocation of dose estimates to clinically/diagnostically relevant exposure groups. Altogether, 105 dose estimates were reported by the eight teams, and the earliest report times on dose categories and estimates were 5 h and 9 h, respectively. The coefficient of variation for 85% of all 436 qRT-PCR measurements did not exceed 10%. One team reported dose estimates that systematically deviated several-fold from reported dose estimates, and these outliers were excluded from further analysis. Teams employing a combination of several genes generated about two-times lower median SADs (0.8 Gy) compared to dose estimates based on single genes only (1.7 Gy). When considering the uncertainty intervals for triage dosimetry, dose estimates of all teams together were correctly reported in 100% of the 0 Gy, 50% of the 1.2 Gy and 50% of the 3.5 Gy exposed samples. The order of dose estimates (from lowest to highest) corresponding to three dose categories (unexposed, low dose and highest exposure) were correctly reported by all teams and all chosen genes or gene combinations. Furthermore, if teams reported no exposure or an exposure >3.5 Gy, it was always correctly allocated to the unexposed and the highly exposed group, while low exposed (1.2 Gy) samples sometimes could not be discriminated from highly (3.5 Gy) exposed samples. All teams used FDXR and 78.1% of correct dose estimates used FDXR as one of the predictors. Still, the accuracy of reported dose estimates based on FDXR differed considerably among teams with one team's SAD (0.5 Gy) being comparable to the dose accuracy employing a combination of genes. Using the workflow of this reference team, we performed additional experiments after the exercise on residual RNA and cDNA sent by six teams to the reference team. All samples were processed similarly with the intention to improve the accuracy of dose estimates when employing the same workflow. Re-evaluated dose estimates improved for half of the samples and worsened for the others. In conclusion, this inter-laboratory comparison exercise enabled (1) identification of technical problems and corrections in preparations for future events, (2) confirmed the early and high-throughput capabilities of gene expression, (3) emphasized different biodosimetry approaches using either only FDXR or a gene combination, (4) indicated some improvements in dose estimation with FDXR when employing a similar methodology, which requires further research for the final conclusion and (5) underlined the applicability of gene expression for identification of unexposed and highly exposed samples, supporting medical management in radiological or nuclear scenarios
001010512 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
001010512 588__ $$aDataset connected to DataCite
001010512 7001_ $$0P:(DE-HGF)0$$aAmundson, S. A.$$b1
001010512 7001_ $$0P:(DE-HGF)0$$aBadie, C.$$b2
001010512 7001_ $$0P:(DE-Juel1)133469$$aKriehuber, R.$$b3$$ufzj
001010512 7001_ $$0P:(DE-HGF)0$$aLacombe, J.$$b4
001010512 7001_ $$0P:(DE-HGF)0$$aLopez-Riego, M.$$b5
001010512 7001_ $$0P:(DE-HGF)0$$aLumniczky, K.$$b6
001010512 7001_ $$0P:(DE-HGF)0$$aEndesfelder, D.$$b7
001010512 7001_ $$0P:(DE-HGF)0$$aO'Brien, G.$$b8
001010512 7001_ $$0P:(DE-HGF)0$$aDoucha-Senf, S.$$b9
001010512 7001_ $$0P:(DE-HGF)0$$aGhandhi, S. A.$$b10
001010512 7001_ $$0P:(DE-HGF)0$$aHargitai, R.$$b11
001010512 7001_ $$0P:(DE-HGF)0$$aKis, E.$$b12
001010512 7001_ $$0P:(DE-HGF)0$$aLundholm, L.$$b13
001010512 7001_ $$0P:(DE-Juel1)133339$$aOskamp, D.$$b14$$ufzj
001010512 7001_ $$0P:(DE-HGF)0$$aOstheim, P.$$b15
001010512 7001_ $$0P:(DE-HGF)0$$aSchwanke, D.$$b16
001010512 7001_ $$0P:(DE-HGF)0$$aShuryak, I.$$b17
001010512 7001_ $$0P:(DE-HGF)0$$aSiebenwith, C.$$b18
001010512 7001_ $$0P:(DE-HGF)0$$aUnverricht-Yeboah, M.$$b19
001010512 7001_ $$0P:(DE-HGF)0$$aWojcik, A.$$b20
001010512 7001_ $$0P:(DE-HGF)0$$aZenhausern, F.$$b21
001010512 7001_ $$0P:(DE-HGF)0$$aPort, M.$$b22
001010512 773__ $$0PERI:(DE-600)2135113-2$$a10.1667/RADE-22-00206.1$$gVol. 199, no. 6$$n6$$p598-615$$tRadiation research$$v199$$x0033-7587$$y2023
001010512 8564_ $$uhttps://juser.fz-juelich.de/record/1010512/files/RADE-22-00206.1-1.pdf$$yOpenAccess
001010512 909CO $$ooai:juser.fz-juelich.de:1010512$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
001010512 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133469$$aForschungszentrum Jülich$$b3$$kFZJ
001010512 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133339$$aForschungszentrum Jülich$$b14$$kFZJ
001010512 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
001010512 9141_ $$y2023
001010512 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001010512 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2023-10-25$$wger
001010512 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRADIAT RES : 2022$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-25
001010512 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-25
001010512 9201_ $$0I:(DE-Juel1)S-US-20090406$$kS-US$$lSicherheit und Strahlenschutz, Umgebungsüberwachung,Strahlenbiologie$$x0
001010512 980__ $$ajournal
001010512 980__ $$aVDB
001010512 980__ $$aUNRESTRICTED
001010512 980__ $$aI:(DE-Juel1)S-US-20090406
001010512 9801_ $$aFullTexts